+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Lung Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019

  • ID: 4895173
  • Report
  • December 2019
  • Region: Global
  • 555 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • A&G Pharmaceutical Inc
  • BioMarker Strategies LLC
  • Enterome Bioscience SA
  • MDNA Life Sciences Inc
  • Onconome, Inc. (Inactive)
  • SomaLogic Inc
  • MORE
Lung Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019

Summary

The Medical Devices sector report, “Lung Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019” provides an overview of Lung Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Lung Cancer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Lung Cancer Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Lung Cancer Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Lung Cancer Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • A&G Pharmaceutical Inc
  • BioMarker Strategies LLC
  • Enterome Bioscience SA
  • MDNA Life Sciences Inc
  • Onconome, Inc. (Inactive)
  • SomaLogic Inc
  • MORE
1 Introduction
1.1 Lung Cancer Diagnostic Tests Overview

2 Products under Development
2.1 Lung Cancer Diagnostic Tests - Pipeline Products by Stage of Development
2.2 Lung Cancer Diagnostic Tests - Pipeline Products by Territory
2.3 Lung Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
2.4 Lung Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
2.5 Lung Cancer Diagnostic Tests - Ongoing Clinical Trials

3 Lung Cancer Diagnostic Tests - Pipeline Products under Development by Companies
3.1 Lung Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development
3.2 Lung Cancer Diagnostic Tests - Pipeline Products by Stage of Development

4 Lung Cancer Diagnostic Tests Companies and Product Overview

5 Lung Cancer Diagnostic Tests - Recent Developments

6 Appendix

List of Tables
Table 1: Lung Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Table 2: Lung Cancer Diagnostic Tests - Pipeline Products by Territory
Table 3: Lung Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
Table 4: Lung Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
Table 5: Lung Cancer Diagnostic Tests - Ongoing Clinical Trials
Table 6: Lung Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development
Table 7: Lung Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Table 8: A&G Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Onco 88 - Lung Cancer Diagnostic Tests - Product Status
Table 10: Onco 88 - Lung Cancer Diagnostic Tests - Product Description
Table 11: OncoStain 88 - Lung Cancer Diagnostic Tests - Product Status
Table 12: OncoStain 88 - Lung Cancer Diagnostic Tests - Product Description
Table 13: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 14: ARCHITECT c4000 System - NSE Assay - Product Status
Table 15: ARCHITECT c4000 System - NSE Assay - Product Description
Table 16: ARCHITECT c8000 System - NSE Assay - Product Status
Table 17: ARCHITECT c8000 System - NSE Assay - Product Description
Table 18: ARCHITECT ci4100 Integrated System - NSE Assay - Product Status
Table 19: ARCHITECT ci4100 Integrated System - NSE Assay - Product Description
Table 20: ARCHITECT ci8200 Integrated System - NSE Assay - Product Status
Table 21: ARCHITECT ci8200 Integrated System - NSE Assay - Product Description
Table 22: ARCHITECT i1000SR System - NSE Assay - Product Status
Table 23: ARCHITECT i1000SR System - NSE Assay - Product Description
Table 24: ARCHITECT i2000SR Integrated System - Neuron-Specific Enolase Assay - Product Status
Table 25: ARCHITECT i2000SR Integrated System - Neuron-Specific Enolase Assay - Product Description
Table 26: PRAME Antigen Lung Cancer Assay - Product Status
Table 27: PRAME Antigen Lung Cancer Assay - Product Description
Table 28: Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 29: Diagnostic Assay - Lung Cancer Diagnostic Tests - Product Status
Table 30: Diagnostic Assay - Lung Cancer Diagnostic Tests - Product Description
Table 31: MCM Test - Lung Cancer Diagnostic Tests - Product Status
Table 32: MCM Test - Lung Cancer Diagnostic Tests - Product Description
Table 33: Aberystwyth University Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Diagnostic Biomarker Test - Lung Cancer Diagnostic Tests - Product Status
Table 35: Diagnostic Biomarker Test - Lung Cancer Diagnostic Tests - Product Description
Table 36: Abnova Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Diagnostic Test - ACTN4 - Product Status
Table 38: Diagnostic Test - ACTN4 - Product Description
Table 39: Acobiom Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Companion Diagnostic Test - Lung Cancer Diagnostic Tests - Product Status
Table 41: Companion Diagnostic Test - Lung Cancer Diagnostic Tests - Product Description
Table 42: Diagnostic/Prognostic Assay - Lung Cancer Diagnostic Tests - Product Status
Table 43: Diagnostic/Prognostic Assay - Lung Cancer Diagnostic Tests - Product Description
Table 44: Advanced Marker Discovery SL Pipeline Products & Ongoing Clinical Trials Overview
Table 45: DiagnoLung - Product Status
Table 46: DiagnoLung - Product Description
Table 47: Predictive Diagnostic Test - Lung Cancer Diagnostic Tests - Product Status
Table 48: Predictive Diagnostic Test - Lung Cancer Diagnostic Tests - Product Description
Table 49: Prognostic Test - Lung Cancer Diagnostic Tests - Product Status
Table 50: Prognostic Test - Lung Cancer Diagnostic Tests - Product Description
Table 51: AIT Austrian Institute of Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 52: Biomarker Assay - Lung Cancer Diagnostic Tests - Product Status
Table 53: Biomarker Assay - Lung Cancer Diagnostic Tests - Product Description
Table 54: Almac Diagnostic Services Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 55: Prognostic Test - Early Stage Lung Cancer Diagnostic Tests - Product Status
Table 56: Prognostic Test - Early Stage Lung Cancer Diagnostic Tests - Product Description
Table 57: Prognostic Test - NSCLC - Product Status
Table 58: Prognostic Test - NSCLC - Product Description
Table 59: ANGLE plc Pipeline Products & Ongoing Clinical Trials Overview

List of Figures
Figure 1: Lung Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Figure 2: Lung Cancer Diagnostic Tests - Pipeline Products by Territory
Figure 3: Lung Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
Figure 4: Lung Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
Figure 5: Lung Cancer Diagnostic Tests - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 3
  • A&G Pharmaceutical Inc
  • Abbott Diagnostics
  • Abcodia Ltd
  • Aberystwyth University
  • Abnova Corp
  • Acobiom
  • Advanced Marker Discovery SL
  • AIT Austrian Institute of Technology GmbH
  • Almac Diagnostic Services Ltd
  • ANGLE plc
  • Anixa Diagnostics Corporation
  • Armune BioScience Inc
  • Aurelium BioPharma Inc.
  • Avant Diagnostics Inc
  • BARD1 Life Sciences Ltd
  • BioAffinity Technologies, Inc.
  • Biocept Inc
  • Biodesix Inc
  • Biological Dynamics Inc
  • BioMark Diagnostics Inc
  • BioMarker Strategies LLC
  • BioNTech SE
  • BioSystems International
  • Boston Children's Hospital
  • Cancer Genetics Inc
  • Cancer Research Technology Ltd
  • Cangen Biotechnologies Inc (Inactive)
  • CDI Laboratories Inc
  • Celcuity Inc
  • Cellanyx Diagnostics, Inc.
  • Cellmid Ltd
  • CeMines, Inc. (Inactive)
  • Cepheid
  • Ceres Nanosciences Inc
  • Cernostics Inc
  • ChemImage Corp
  • Clarient Inc
  • Courtagen Life Sciences Inc
  • DiagnoCure Inc. (Inactive)
  • EDP Biotech Corporation
  • Emory University
  • Enterome Bioscience SA
  • Epic Sciences Inc
  • Epigenomics AG
  • Eventus Diagnostics Inc (Inactive)
  • Exact Sciences Corp
  • Exiqon AS
  • Exosomics Siena SpA
  • Fahy Gurteen UK Ltd
  • FibroStatin SL
  • Fina Biotech SL
  • French National Institute of Health and Medical Research
  • Gene Express, Inc. (Inactive)
  • GeneCentric Diagnostics, Inc.
  • Global Discovery Biosciences Corporation
  • GlycoZym
  • Guardant Health Inc
  • ImmunoCellular Therapeutics Ltd
  • Immunovia AB
  • Insight Genetics Inc
  • InterGenetics Inc
  • IV Diagnostics Inc
  • Louisville Bioscience, Inc.
  • Massachusetts General Hospital
  • MDNA Life Sciences Inc
  • MDxHealth SA
  • MEDITE Cancer Diagnostics Inc
  • Memory Dx LLC
  • Merrimack Pharmaceuticals Inc
  • Metabolon Inc
  • Metanomics Health GmbH
  • MetaStat Inc
  • Milagen Inc
  • Myriad International GmbH
  • Nagoya University
  • Nanocytomics LLC
  • Nanostics Inc
  • NEOMICS Co Ltd
  • NovaGray
  • Novel Bio-spectrum Technologies Inc (Inactive)
  • Oncimmune (USA) LLC
  • OncoCyte Corp
  • Oncolome Diagnostics Inc (Inactive)
  • Onconome, Inc. (Inactive)
  • OncoStem Diagnostics Pvt. Ltd
  • On-Q-ity, Inc. (Inactive)
  • OPKO Health Inc
  • Orion Genomics LLC
  • OTraces Inc.
  • Peri Rx Inc
  • PleX Diagnostics Inc (Inactive)
  • PreMD Inc (Inactive)
  • Proplex Technologies Llc
  • Proteome Sciences Plc
  • Proteomika (Inactive)
  • Quanterix Corp
  • Queensland University of Technology
  • Research Center Borstel
  • Roche Diagnostics International Ltd
  • Rosetta Genomics Ltd
  • Roswell Park Cancer Institute
  • Savicell Diagnostic Ltd.
  • Sengenics International Pte Ltd
  • Shenzhen Mindray Bio-Medical Electronics Co Ltd
  • Sienna Cancer Diagnostics Ltd
  • Simon Fraser University
  • SomaLogic Inc
  • Southern Illinois University Carbondale
  • StageZero Life Sciences Ltd
  • Sysmex Corp
  • The Prince Charles Hospital
  • Thermo Fisher Scientific Inc
  • Transgene SA
  • Treos Bio Inc
  • Universal Diagnostics SL
  • University of California San Francisco
  • University of Chicago
  • University of Colorado
  • University of Maryland
  • University of Queensland
  • University of South Florida
  • University of Texas MD Anderson Cancer Center
  • US Biomarkers Inc
  • Vanderbilt University
  • Ventana Medical Systems Inc
  • Viomics Inc.
  • VisionGate Inc
  • VolitionRX Ltd
  • XEPTAGEN SpA
  • Zetiq Technologies Ltd
  • ZORA Biosciences Oy
Note: Product cover images may vary from those shown
Adroll
adroll